Oesophageal adenocarcinoma stage III – Life with Disease

Go back

Stage III oesophageal adenocarcinoma represents a critical point in the cancer journey, where the disease has advanced beyond the inner layers of the oesophagus and may involve nearby lymph nodes, yet treatment still offers hope and meaningful intervention possibilities.

Understanding the Prognosis

Receiving a diagnosis of stage III oesophageal adenocarcinoma can feel overwhelming, and it’s natural to want to understand what the future may hold. At this stage, the cancer has grown beyond the oesophagus itself and may have reached nearby tissues or lymph nodes, which makes the prognosis more challenging than earlier stages, but individual outcomes can vary significantly based on many factors including overall health, response to treatment, and specific characteristics of the cancer.[2]

Statistics provide a general picture, though they cannot predict what will happen in any individual case. According to data from England covering people diagnosed between 2016 and 2020, around 20 out of 100 people with stage 3 oesophageal cancer survive their cancer for 5 years or more after diagnosis.[17] These figures represent averages across many people and don’t account for what specific treatments people received or their individual circumstances. Some people live much longer than these statistics suggest, while others may face more difficulties.

The outlook depends on several important factors that your medical team will consider. These include how well the cancer responds to chemotherapy and radiation, whether surgery is possible and successful, your overall physical fitness before and during treatment, and whether the cancer has spread to lymph nodes and how many are affected.[2] Your age, nutritional status, and ability to tolerate intensive treatments also play important roles in determining outcomes.

⚠️ Important
Survival statistics are based on large groups of people and represent averages. They cannot predict what will happen to you personally. Your doctor can provide more specific information based on your individual situation, including your overall health, the specific features of your cancer, and how well you respond to treatment.

Natural Progression Without Treatment

Understanding how stage III oesophageal adenocarcinoma develops when left untreated helps explain why early and comprehensive intervention is so important. At this stage, the cancer has already grown through multiple layers of the oesophagus wall and may have spread to nearby lymph nodes, which are small bean-shaped structures that help fight infection.[2]

Without treatment, the cancer continues to expand both locally and potentially to distant parts of the body. The tumour grows larger within the oesophagus, progressively narrowing the passage that food travels through from the mouth to the stomach. This leads to increasing difficulty swallowing, first with solid foods and eventually even with liquids, which can result in severe malnutrition and weight loss.[7]

As the cancer advances, it may invade neighbouring structures. In stage III disease, the cancer might have already reached or may soon spread into nearby tissues such as the covering of the lungs called the pleura, the outer covering of the heart known as the pericardium, or the diaphragm, which is the large muscle at the bottom of the rib cage that helps with breathing.[2] When these structures become involved, new symptoms can develop including chest pain, difficulty breathing, or persistent cough.

The cancer can also spread through the lymphatic system to more distant lymph nodes and eventually to other organs. Common sites where oesophageal cancer spreads include the liver, lungs, distant lymph nodes, bones, and the peritoneum, which is the lining of the abdominal cavity.[15] When cancer spreads in this way, it becomes more difficult to control and causes additional symptoms related to whichever organs are affected.

Possible Complications

Stage III oesophageal adenocarcinoma can lead to various complications, both from the cancer itself and sometimes from the treatments needed to control it. Understanding these potential challenges helps patients and families prepare and recognize when medical attention might be needed.

One of the most significant complications is severe difficulty swallowing, called dysphagia. As the tumour grows, it can block the oesophagus partially or completely, making it extremely difficult or impossible to eat normally. This can lead to dangerous weight loss and malnutrition, which weakens the body and makes it harder to tolerate cancer treatments. Many patients require feeding tubes to maintain adequate nutrition during treatment, which can be placed through the nose, through the abdominal wall into the stomach, or sometimes directly into the small intestine.[6]

Pain is another common complication. The cancer can cause pain behind the breastbone as it grows and presses on surrounding tissues. If it spreads to bones, this can cause bone pain. Pain can also result from the cancer invading nerve pathways or from treatment-related inflammation.[7] Fortunately, there are many effective ways to manage cancer-related pain, and controlling pain is an important part of comprehensive cancer care.

Bleeding from the tumour is possible, though not always obvious. The cancer can erode blood vessels in the oesophagus wall, leading to either slow, chronic bleeding that causes anaemia, or occasionally more rapid bleeding that can be frightening and requires immediate medical attention. Signs of bleeding might include vomiting blood, passing black tarry stools, or simply feeling increasingly tired and weak due to low blood counts.

Respiratory complications can develop if the cancer spreads to the lungs or if fluid accumulates around the lungs, a condition called pleural effusion. This can cause shortness of breath, coughing, and reduced ability to exercise or perform daily activities. If the cancer affects structures near the airway, there’s also a risk of developing an abnormal connection between the oesophagus and the windpipe called a fistula, which can lead to severe coughing during eating or drinking and increases the risk of lung infections.

Treatment-related complications are also important to understand. Chemotherapy and radiation can cause side effects including fatigue, nausea, temporary hair loss, mouth sores, and increased risk of infections due to lowered white blood cell counts. Surgery for oesophageal cancer is major and carries risks such as infections, problems with wound healing, leakage where the oesophagus is reconnected, and changes in how the digestive system works.[9]

Impact on Daily Life

Living with stage III oesophageal adenocarcinoma brings significant changes to daily life that affect not just physical capabilities but also emotional well-being, social relationships, work, and personal interests. Understanding these impacts helps patients and families adjust and find new ways to maintain quality of life during and after treatment.

The physical effects are often the most immediately noticeable. Difficulty swallowing means that mealtimes, which are usually social and pleasurable occasions, become challenging and sometimes stressful. Many patients find they can only eat small amounts at a time and must eat very slowly, chewing food thoroughly or switching to soft foods and liquids. Some people experience pain when swallowing, which can make eating even more difficult. Weight loss is common and can lead to weakness, fatigue, and reduced ability to do physical activities that were once easy.[19]

After surgery to remove part of the oesophagus, called an esophagectomy, the digestive system functions differently. The stomach is often made smaller or reconstructed, which means patients need to eat four to six smaller meals throughout the day instead of three large ones. Some people experience reflux, where stomach contents come back up, or dumping syndrome, where food moves too quickly through the digestive system causing cramping, diarrhoea, and low blood sugar.[9]

Fatigue is a major issue during treatment and recovery. Chemotherapy, radiation, and surgery all cause tiredness that goes beyond normal fatigue and doesn’t improve much with rest. This can make it difficult to work, care for family members, or engage in hobbies and social activities. Many people need to reduce their work hours or take extended leave during treatment.

The emotional and psychological impact can be profound. Anxiety about the cancer, its treatment, and the future is completely normal and understandable. Some people experience depression, especially when dealing with difficult symptoms, treatment side effects, or limitations in their abilities. Fear about recurrence or progression of cancer can persist even after successful treatment. Changes in appearance due to weight loss or treatment side effects may affect self-esteem and body image.

Social relationships often change. Some people find it difficult to explain their condition to friends or colleagues, or they may feel isolated because others don’t understand what they’re going through. On the other hand, many patients discover that facing cancer deepens their relationships with family and close friends, and they find unexpected support from their community.[19]

Work life is frequently disrupted. Treatment schedules with chemotherapy, radiation appointments, and recovery from surgery require significant time away from work. Some people can work part-time or from home during less intensive treatment phases, while others need to stop working entirely for a period. Financial concerns about medical costs and reduced income add another layer of stress.

However, many people find ways to adapt and maintain meaning in their lives. Some helpful strategies include setting small, achievable daily goals; finding ways to stay connected with loved ones; engaging in gentle physical activity as recommended by doctors; pursuing modified versions of hobbies; using relaxation techniques like meditation or gentle yoga; and connecting with other people facing similar challenges through support groups.[19] Many patients emphasize the importance of focusing on what they can still do rather than what they can no longer do, and finding new sources of joy and purpose.

Support for Family Members and Clinical Trials

When someone is diagnosed with stage III oesophageal adenocarcinoma, the entire family is affected. Family members and close friends play a crucial role in supporting the patient, but they also need information and support themselves, particularly when it comes to understanding treatment options including clinical trials.

Clinical trials are research studies that test new treatments or new combinations of existing treatments to find better ways to help patients with cancer. For stage III oesophageal cancer, clinical trials might investigate new chemotherapy drugs, targeted therapies that attack specific features of cancer cells, immunotherapy drugs that help the immune system fight cancer, new radiation techniques, or different sequences of combining treatments.[6][11]

Understanding what clinical trials offer is important for families. Trials give patients access to the newest treatments before they become widely available. Participants in clinical trials receive very careful monitoring and attention from medical teams. While there are no guarantees about outcomes, clinical trials may offer hope when standard treatments have limited effectiveness. All clinical trials must meet strict ethical standards to protect participants, and patients can always choose to leave a trial if they wish.

Family members can help their loved one explore clinical trial options in several practical ways. They can ask the oncology team whether there are any suitable trials available for the patient’s specific situation. Many cancer centres maintain lists of active trials, and websites exist where families can search for trials by cancer type and location. When a potential trial is identified, family members can help gather questions to ask the research team, such as what the trial involves, what the potential benefits and risks are, how it compares to standard treatment, and what the time commitment would be.

Helping prepare for trial participation involves understanding that extensive testing is usually required to determine whether someone qualifies for a specific trial. There will be detailed consent processes where all aspects of the research are explained. Family members can attend these discussions, take notes, and help ensure that all questions are answered. They can also help coordinate the logistics, as clinical trials often require more frequent visits to the treatment centre than standard care.

Beyond clinical trials, families provide invaluable support in many other ways. Practical help with transportation to appointments, preparing appropriate meals, managing medications, and keeping track of symptoms and side effects makes a real difference. Emotional support through listening, being present, maintaining hope while being realistic, and helping maintain connections with the wider community is equally important. Family members should also remember to take care of their own physical and emotional health, as supporting someone through cancer treatment is demanding and can lead to caregiver burnout if self-care is neglected.[24]

⚠️ Important
Caregivers and family members face their own emotional challenges when supporting someone with cancer. It’s essential that they also seek support through caregiver support groups, counselling services, or simply maintaining their own social connections. Taking care of yourself enables you to better care for your loved one.

💊 Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of this condition, based only on the provided sources:

  • Capecitabine (Xeloda) – Chemotherapy drug used to treat stage 3 oesophageal cancer, often in combination with other medications
  • Cisplatin – Chemotherapy drug commonly combined with other agents for treating stage 3 oesophageal cancer
  • Fluorouracil – Chemotherapy drug used in various combinations for stage 3 oesophageal cancer treatment
  • Carboplatin – Chemotherapy drug used in combination with other medications for stage 3 oesophageal cancer
  • Paclitaxel – Chemotherapy drug used in treatment combinations for stage 3 oesophageal cancer
  • Epirubicin – Chemotherapy drug used in various combination regimens for stage 3 oesophageal cancer
  • Docetaxel (Taxotere) – Chemotherapy drug used in combination with other agents for stage 3 oesophageal cancer
  • Oxaliplatin – Chemotherapy drug used in various combinations for treating stage 3 oesophageal cancer
  • Etoposide (Vepesid) – Chemotherapy drug used in combination with other medications for stage 3 oesophageal cancer
  • Irinotecan – Chemotherapy drug used in combination regimens for stage 3 oesophageal cancer
  • Leucovorin – Medication used to enhance the effectiveness of fluorouracil chemotherapy
  • Trastuzumab – Targeted therapy used for HER2-positive adenocarcinoma tumours, combined with chemotherapy
  • Ramucirumab (Cyramza) – Monoclonal antibody that blocks blood vessel formation in tumours, given with paclitaxel
  • Zolbetuximab (Vyloy) – Monoclonal antibody targeting Claudin 18.2 protein on cancer cells to stop their growth
  • Pembrolizumab (Keytruda) – Immunotherapy drug used in combination with chemotherapy for certain types of stage 3 oesophageal cancer
  • Nivolumab (Opdivo) – Immunotherapy drug used after surgery or in combination with chemotherapy for stage 3 oesophageal cancer
  • Ipilimumab (Yervoy) – Immunotherapy drug that may be used in combination treatment for stage 3 oesophageal cancer

Ongoing Clinical Trials on Oesophageal adenocarcinoma stage III

  • Study of Nivolumab or Placebo for Patients with Removed Esophageal or Gastroesophageal Junction Cancer

    Not recruiting

    1 1 1
    Investigated drugs:
    Belgium Czechia Denmark France Germany Ireland +4

References

https://www.cancer.gov/publications/dictionaries/cancer-terms/def/stage-iii-esophageal-adenocarcinoma

https://www.cancerresearchuk.org/about-cancer/oesophageal-cancer/stages-types-and-grades/stage-3

https://www.texasoncology.com/types-of-cancer/esophageal-cancer/stage-iii-esophageal-cancer

https://www.healthline.com/health/oral-cancer/esophageal-cancer-staging

https://surgicaloncology.ucsf.edu/condition/esophageal-cancer

https://cancer.ca/en/cancer-information/cancer-types/esophageal/treatment/stage-3

https://vicc.org/cancer-info/adult-esophageal-cancer

https://www.roswellpark.org/cancer/esophageal/diagnosis/staging

https://www.saintjohnscancer.org/blog/gastrointestinal/advice-from-a-stage-3-esophageal-cancer-survivor/

https://www.texasoncology.com/types-of-cancer/esophageal-cancer/stage-iii-esophageal-cancer

https://cancer.ca/en/cancer-information/cancer-types/esophageal/treatment/stage-3

https://www.cancerresearchuk.org/about-cancer/oesophageal-cancer/stages-types-and-grades/stage-3

https://www.cancer.org/cancer/types/esophagus-cancer/treating.html

https://www.cancer.gov/types/esophageal/patient/esophageal-treatment-pdq

https://www.ncbi.nlm.nih.gov/books/NBK459267/

https://www.dana-farber.org/cancer-care/types/esophageal-cancer/treatment

https://www.cancerresearchuk.org/about-cancer/oesophageal-cancer/survival

https://www.roswellpark.org/cancertalk/202305/stage-3-esophageal-cancer-jts-story

https://thepatientstory.com/patient-stories/esophageal-cancer/dan-r/

https://www.saintjohnscancer.org/blog/gastrointestinal/advice-from-a-stage-3-esophageal-cancer-survivor/

https://www.cancerresearchuk.org/about-cancer/oesophageal-cancer/stages-types-and-grades/stage-3

https://www.mskcc.org/cancer-care/patient-education/nutrition-during-treatment-esophageal-cancer

https://www.texasoncology.com/types-of-cancer/esophageal-cancer/stage-iii-esophageal-cancer

https://pmc.ncbi.nlm.nih.gov/articles/PMC7575932/

https://www.mayoclinic.org/diseases-conditions/esophageal-cancer/diagnosis-treatment/drc-20356090

https://medlineplus.gov/diagnostictests.html

https://www.questdiagnostics.com/

https://www.healthdirect.gov.au/diagnostic-tests

https://www.who.int/health-topics/diagnostics

https://www.yalemedicine.org/clinical-keywords/diagnostic-testsprocedures

https://www.nibib.nih.gov/science-education/science-topics/rapid-diagnostics

https://www.health.harvard.edu/diagnostic-tests-and-medical-procedures

https://www.roche.com/stories/terminology-in-diagnostics

FAQ

What exactly does stage III oesophageal adenocarcinoma mean?

Stage III oesophageal adenocarcinoma means the cancer has grown beyond the outer layer of the oesophagus and may have spread into nearby tissues such as the covering of the lungs, the outer covering of the heart, or the diaphragm. The cancer might also have spread to up to 6 nearby lymph nodes, but there is no sign of it spreading to distant parts of the body.

What treatments are typically used for stage III oesophageal adenocarcinoma?

Treatment usually involves a combination approach including chemotherapy combined with radiation therapy (called chemoradiation), often given before surgery. Surgery to remove part of the oesophagus and affected lymph nodes may follow if the patient is healthy enough. Some patients also receive immunotherapy drugs after surgery. For those who cannot have surgery, chemoradiation may be offered as the main treatment.

Will I need a feeding tube during treatment?

Many patients with stage 3 oesophageal cancer have a feeding tube placed so they can gain weight and maintain good nutrition during treatment. This is because the tumour can make swallowing difficult, and treatments can temporarily worsen this problem. The feeding tube helps ensure your body gets the nutrition it needs to tolerate treatment and heal properly.

How long will my treatment take?

Based on patient experiences, a typical treatment course might include chemotherapy lasting about 6 weeks, followed by 30 days of radiation therapy, then approximately 60 days of rest before surgery. After surgery, some patients continue with additional immunotherapy for up to one year. However, the exact timeline varies depending on individual circumstances and how the cancer responds to treatment.

Can I participate in a clinical trial for stage III oesophageal cancer?

Clinical trials are research studies testing new treatments and may be an option for patients with stage III oesophageal cancer. These trials might investigate new chemotherapy drugs, targeted therapies, immunotherapy drugs, or different combinations of treatments. Ask your oncology team whether there are suitable trials available for your specific situation, and they can help you understand the potential benefits, risks, and requirements for participation.

🎯 Key takeaways

  • Stage III oesophageal adenocarcinoma has spread beyond the oesophagus to nearby tissues or lymph nodes but not to distant organs, with around 20% of patients surviving 5 years or more after diagnosis
  • Treatment typically combines chemotherapy, radiation therapy, and surgery, with some patients also receiving targeted therapies or immunotherapy depending on their cancer’s specific characteristics
  • Difficulty swallowing is a major complication requiring careful nutritional management, often including feeding tubes to maintain adequate nutrition during intensive treatment
  • After esophagectomy surgery, patients must adapt to eating 4-6 smaller meals daily due to stomach reconstruction, which requires permanent lifestyle adjustments
  • Minimally invasive robotic-assisted surgery has become available for some patients, potentially offering benefits over traditional open surgery
  • Clinical trials provide access to cutting-edge treatments and families can help by researching options, asking questions, and supporting the logistics of participation
  • The emotional impact on patients and families is significant, but many find that maintaining small daily habits, staying connected with loved ones, and focusing on what’s still possible brings meaning during treatment
  • Comprehensive palliative care addressing pain, psychological symptoms, and quality of life should be integrated throughout treatment, not just at the end of life

Connected medications: